Hypermenorrhea (Heavy Menstrual Bleeding)

What is Hypermenorrhea?

Hypermenorrhea, also known as heavy menstrual bleeding (HMB), is a condition in which a woman loses an unusually large amount of blood during each menstrual cycle. The World Health Organization defines it as “excessive menstrual blood loss that interferes with a woman’s physical, emotional, social and material quality of life.”

In practical terms, hypermenorrhea often means:

• Changing a regular pad or tampon every hour for several consecutive hours.
• Soaking through one or more sanitary products every night.
• Bleeding that lasts longer than seven days.
• Developing anemia or feeling fatigued because of the blood loss.

While occasional heavy flow can be a normal variation, persistent hypermenorrhea warrants evaluation because it can signal an underlying medical problem and lead to iron‑deficiency anemia, reduced quality of life, and social or occupational disruption.

Common Causes

Heavy menstrual bleeding usually results from a disturbance in the hormonal regulation of the endometrium (the lining of the uterus) or from structural problems within the uterus. The most frequent causes include:

• Uterine fibroids (leiomyomas): Benign smooth‑muscle tumors that can increase the surface area of the uterine lining.
• Endometrial polyps: Small growths on the uterine lining that may disrupt normal shedding.
• Adenomyosis: Endometrial tissue that grows into the uterine muscle, causing a bulky uterus and heavy bleeding.
• Hormonal imbalance: Particularly an excess of estrogen relative to progesterone (often seen in perimenopause).
• Coagulation disorders: Von Willebrand disease, platelet function defects, or clotting factor deficiencies.
• Iatrogenic causes: Use of intrauterine devices (especially non‑hormonal copper IUDs), or hormonal contraceptives that are not ideal for the individual.
• Thyroid dysfunction: Both hypothyroidism and hyperthyroidism can alter menstrual flow.
• Endometrial hyperplasia: Overgrowth of the uterine lining which may be benign or precancerous.
• Pelvic inflammatory disease (PID) or chronic endometritis: Persistent inflammation can affect shedding.
• Cancer: Uterine (endometrial) carcinoma is rare in younger women but must be excluded in persistent, unexplained bleeding.

Associated Symptoms

Women with hypermenorrhea often notice other signs that accompany the heavy flow:

• Fatigue, weakness, or shortness of breath due to iron‑deficiency anemia.
• Dizziness or fainting spells.
• Swelling or tenderness in the lower abdomen.
• Spotting or bleeding between periods.
• Pelvic pressure or a sensation of a “full” uterus (common with fibroids or adenomyosis).
• Changes in bowel or bladder habits (e.g., frequent urination if a fibroid is pressing on the bladder).
• Skin changes such as pale complexion, brittle nails, or spoon‑shaped nails (koilonychia) indicating chronic anemia.

When to See a Doctor

Although occasional heavy periods may be benign, you should schedule a medical appointment if any of the following occur:

• Needing to change protection every hour for two or more consecutive hours.
• Bleeding that lasts more than 7 days or that recurs before you expect your next period.
• Symptoms of anemia – persistent fatigue, shortness of breath, rapid heartbeat, or pale skin.
• Sudden increase in flow after previously normal periods.
• Bleeding after intercourse, between periods, or after menopause.
• Pelvic pain, pelvic pressure, or a palpable mass.
• History of a clotting disorder, thyroid disease, or use of anticoagulant medication.

Early evaluation can prevent complications and allow targeted therapy.

Diagnosis

Diagnosing hypermenorrhea involves a combination of history taking, physical examination, laboratory tests, and imaging. The typical step‑wise approach is:

1. Detailed Medical History

• Duration, frequency, and pattern of bleeding.
• Associated symptoms (pain, clotting, anemia signs).
• Medication review (anticoagulants, hormonal contraceptives, NSAIDs).
• Family history of bleeding disorders or uterine pathology.

2. Physical Examination

• General assessment for pallor, tachycardia, or signs of anemia.
• Abdominal and pelvic exam to feel for uterine enlargement, fibroids, or masses.

3. Laboratory Tests

• Complete blood count (CBC): Detects anemia, platelet count.
• Serum ferritin & iron studies: Evaluate iron stores.
• Coagulation profile: PT, aPTT, and specific assays for von Willebrand disease if indicated.
• Thyroid function tests (TSH, free T4): Exclude thyroid dysfunction.
• Pregnancy test (always rule out pregnancy‑related bleeding).

4. Imaging

• Transvaginal pelvic ultrasound: First‑line to identify fibroids, polyps, adenomyosis, or endometrial thickness.
• Sonohysterography (saline‑infused ultrasound): Improves detection of intracavitary lesions.
• MRI of the pelvis: Reserved for complex cases where adenomyosis or deep infiltrating fibroids are suspected.

5. Endometrial Assessment

• Endometrial biopsy: Recommended for women over 35 (or younger with risk factors) to rule out hyperplasia or cancer.
• Hysteroscopy: Direct visualization and removal of polyps or submucosal fibroids.

Treatment Options

Treatment is individualized based on the underlying cause, severity of bleeding, reproductive plans, and patient preferences. Options fall into two broad categories: medical (pharmacologic) and procedural.

Medical Management

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): Reduce prostaglandin production, which can decrease blood loss by up to 30 % (e.g., ibuprofen 400‑600 mg q6h). Contraindicated in ulcer disease or significant renal impairment.
• Tranexamic acid (TXA): An antifibrinolytic that can cut menstrual blood loss by ~50 % when taken 1 g three times daily for 5 days each cycle (Mayo Clinic).
• Combined oral contraceptives (COCs): Regulate hormone levels, thicken the endometrial lining, and often reduce flow.
• Progesterone‑only options: Oral micronized progesterone, depot medroxyprogesterone acetate (DMPA), or the levonorgestrel intrauterine system (LNG‑IUS, Mirena). The LNG‑IUS can reduce menstrual blood loss by up to 90 % and may lead to amenorrhea after 1‑2 years (Cleveland Clinic).
• Gonadotropin‑releasing hormone (GnRH) agonists/antagonists: Short‑term use (3–6 months) to shrink fibroids or suppress adenomyosis; must be followed by add‑back therapy to avoid bone loss.
• Selective progesterone receptor modulators (SPRMs): Ulipristal acetate (used for fibroids) can improve bleeding patterns.
• Iron supplementation: Oral ferrous sulfate (325 mg PO bid) or intravenous iron for severe deficiency.

Procedural / Surgical Options

• Endometrial ablation: Destroys the uterine lining; suitable for women who have completed childbearing. Success rates >80 % for reducing or eliminating bleeding.
• Myomectomy: Surgical removal of fibroids, either hysteroscopic (submucosal) or laparoscopic/open (intramural). Preserves fertility.
• Uterine artery embolization (UAE): Radiologic occlusion of arterial supply to fibroids; minimally invasive with good control of bleeding.
• Hysterectomy: Definitive cure; considered only after other options have failed or when cancer is present.
• Polypectomy or hysteroscopic resection: For identified polyps or small submucosal fibroids.

Home and Lifestyle Measures

• Track menstrual flow with a diary or a menstrual‑tracking app; this information helps the clinician gauge treatment response.
• Maintain a diet rich in iron (red meat, legumes, fortified cereals) and vitamin C to enhance absorption.
• Stay hydrated and engage in regular moderate exercise, which can improve overall blood volume and reduce fatigue.
• Avoid excessive NSAID use without physician guidance, as it can worsen anemia.

Prevention Tips

While every woman may not be able to prevent hypermenorrhea, certain strategies can lower risk or lessen severity:

• Regular gynecologic exams to detect fibroids, polyps, or endometrial changes early.
• Manage chronic conditions—keep thyroid function, blood pressure, and diabetes under control.
• Limit exposure to endocrine‑disrupting chemicals (e.g., certain plastics, pesticides) that may affect hormone balance.
• If you have a known bleeding disorder, follow your hematology specialist’s recommendations and inform any obstetrician/gynecologist before procedures.
• Use hormonal contraception consistently if it has been shown to regulate your cycle, but discuss long‑term plans with a provider.

Emergency Warning Signs

Bottom Line

Hypermenorrhea is more than just “a heavy period.” It can signal underlying uterine pathology, hormonal disturbances, or systemic bleeding disorders. Prompt evaluation, accurate diagnosis, and personalized treatment—ranging from simple NSAIDs to minimally invasive surgery—can restore a normal menstrual pattern, prevent anemia, and improve quality of life. If you notice any of the warning signs listed above, do not wait—consult a health‑care professional right away.

References:

• Mayo Clinic. “Heavy Menstrual Bleeding.” https://www.mayoclinic.org
• Cleveland Clinic. “Menstrual Disorders – Heavy Bleeding.” https://my.clevelandclinic.org
• American College of Obstetricians and Gynecologists (ACOG). “Management of Abnormal Uterine Bleeding.” Practice Bulletin No. 150, 2015.
• World Health Organization. “Haemorrhage and Hemostasis.” WHO Guidelines, 2023.
• National Institutes of Health. “Iron‑Deficiency Anemia.” https://www.nhlbi.nih.gov
• CDC. “Bleeding Disorders.” https://www.cdc.gov